About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT06976125

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

Urinary tract infection (UTI) is when bacteria enter the urinary system and cause an infection. UTIs cause symptoms including burning when peeing, a feeling of an increased urge to pee, and cloudy or ...

Lead sponsor: University Hospitals Cleveland Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jessica Abou Zeki

CONTACT

216-286-0603 Jessica.AbouZeki@UHhospitals.org

Sponsors

Lead Sponsor

University Hospitals Cleveland Medical Center

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Female sex
•Age \>18 years old
•Discharged from the hospital after ER visit
•Discharge ICD code consistent with a UTI diagnosis
•Antibiotic prescribed for UTI at the time of discharge

Exclusion Criteria

•Male sex
•Necessity for chronic bladder catheterization or discharge with a urinary catheter
•Patients who have an Emergency Severity Index (ESI) of 1 and 2
•Patients who verbalize to the study team member that their pain is a 6 or higher
•Patient set to be transferred to inpatient care
•History of bladder augmentation
•Pregnancy (this will be confirmed with a negative pregnancy test which is ordered in the ER)

Related studies

RECRUITINGPhase 2

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

NCT05488340 · Urinary Tract Infections

Evaluation of the Effectiveness and Safety of a Vaginal Gel for Prevention of Recurrent Urinary Tract Infections

NCT07233473 · Urinary Tract Infections (UTIs)

RECRUITINGPhase 4

Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis

NCT07186465 · Cystitis, Recurrent, Urinary Tract Infections

RECRUITINGPhase 3

Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women

NCT07184827 · Recurrent Urinary Tract Infections in Women

Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment

NCT04846803 · Recurrent Urinary Tract Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 8, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment47

Start dateFeb 2026

Last updatedApr 8, 2026

Condition

Urinary Tract Infections

Locations shown

University Hospitals Cleveland Medical Center

Cleveland, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 8, 2026Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions